Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 16, 2024

BUY
$1.74 - $2.31 $98,468 - $130,725
56,591 Added 49.72%
170,420 $359,000
Q3 2023

Nov 15, 2023

BUY
$2.11 - $3.28 $240,179 - $373,359
113,829 New
113,829 $241,000
Q4 2022

Feb 13, 2023

BUY
$2.03 - $2.42 $56,588 - $67,459
27,876 Added 269.28%
38,228 $93,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $17,287 - $30,434
10,352 New
10,352 $24,000
Q2 2022

Aug 09, 2022

SELL
$1.19 - $1.65 $198,634 - $275,418
-166,920 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$0.99 - $1.6 $59,640 - $96,388
-60,243 Reduced 26.52%
166,920 $227,000
Q4 2021

Feb 14, 2022

BUY
$1.22 - $1.72 $1,299 - $1,831
1,065 Added 0.47%
227,163 $277,000
Q3 2021

Nov 12, 2021

BUY
$1.2 - $1.5 $127,533 - $159,417
106,278 Added 88.7%
226,098 $310,000
Q2 2021

Aug 05, 2021

SELL
$1.25 - $1.83 $55,991 - $81,971
-44,793 Reduced 27.21%
119,820 $169,000
Q1 2021

May 10, 2021

SELL
$1.52 - $2.1 $163,678 - $226,134
-107,683 Reduced 39.55%
164,613 $260,000
Q4 2020

Feb 03, 2021

BUY
$1.55 - $2.05 $374,216 - $494,931
241,430 Added 782.19%
272,296 $433,000
Q3 2020

Nov 06, 2020

BUY
$1.59 - $2.19 $49,076 - $67,596
30,866 New
30,866 $54,000
Q4 2018

Feb 12, 2019

SELL
$0.98 - $1.85 $20,972 - $39,590
-21,400 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$1.76 - $6.38 $37,664 - $136,532
21,400 New
21,400 $38,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.32B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.